A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women

NCT01735422 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Infertility

Interventions

DRUG: r-hFSH
DRUG: r-hLH
DRUG: u-hCG

Sponsor

Merck KGaA, Darmstadt, Germany